by professional phagocytes such as macrophages. 12 In contrast, necrosis was thought to be accidental, associated with rapid loss of cell membrane integrity and inflammation. 12 However, experimental evidence accumulated over the past decade asserts that certain forms of necrosis are actually regulated by well-orchestrated signaling networks and should be considered as programmed necrosis or necroptosis. 13, 14 Receptor-interacting serine/threonineprotein kinase 3 (RIP3) and a closely related kinase called RIP1 have been identified as critical mediators in initiating the necroptosis process. 13, 14 Expression of RIP3 is crucial in the determination of necroptotic cell fate. 15, 16 Cells deficient in RIP3 or treated with RIP1 kinase inhibitors are protected from necroptosis. 15, [17] [18] [19] Mice lacking Rip3 develop normally and are fertile, 17 providing an invaluable tool for in vivo investigations of necroptosis. In contrast, Rip1 −/− mice die shortly after birth. 20 Necrostatin-1 and an optimized derivative of necrostatin-1 (7-Cl-O-Nec-1) are small molecule inhibitors of RIP1. 18, 19, 21 The use of RIP3deficient mice, as well as necrostatin-1 and 7-Cl-O-Nec-1, has demonstrated the significance of necroptosis in several animal models of human diseases, including ischemic brain injury, 18 photoreceptor loss, 22 myocardial infarction, 23 systemic inflammatory stress syndrome, 24 and atherosclerosis. 16 Necroptosis, as well as activation of RIP3, can be triggered by a variety of signals, including cytokines, pathogen-associated molecular patterns, and oxidative stress, all of which are known to be elevated in AAA. 13 In this study, we tested the hypothesis that RIP3 contributes to aneurysm pathophysiology and therefore serves as a significant therapeutic target. Using an AAA model induced by elastase, we demonstrated that Rip3 deficiency prevented aneurysm formation likely through mediating aortic cell death and inflammation. Our data further identified a necroptosis-independent function of RIP3 in nuclear factor-κB (NFκB)mediated inflammatory response. Finally, we investigated the role of protein kinase C-delta (PKCδ) in the regulation of RIP3 expression and SMC necroptosis. Our results provide new insights into pathophysiology of AAA, as well as other vascular diseases associated with cell death or NFκB signaling dysregulation.
Elastase-Induced Murine Abdominal Aortic Aneurysm
Male mice aged 8 to 12 weeks underwent an elastase-induced AAA model, as described previously. 4, 10, 28 All the elastase-treated mice were perfused with elastase for 5 minutes. As a control, a separate group of mice were treated with equal concentration of heat-inactivated (100°C for 15 minutes) elastase for 5 minutes. The diameter of the largest portion of an abdominal aorta was measured and recorded before elastase perfusion and at euthanization. A percentage increase in maximal external aortic diameter was calculated. As shown in Figure 2A and Online Figure I, aortic infusion with heat-inactivated elastase or elastase caused a 29.889±4.644% (0.71±0.02 mm) or 157.366±9.973% (1.42±0.06 mm) expansion in the wild-type (WT) mice, respectively. This is consistent with what was reported in the literature. 28
Orthotopic Allograft Transplantation
Orthotopic allograft transplantation of elastase-treated abdominal aorta was performed as reported recently. 29
Adenoviral Vectors and Infection
Adenoviral vectors expressing PKCδ and empty vector (AdNull) were constructed and purified by cesium chloride gradient centrifuging, as previously described. 26, 27 The adenoviral vectors expressing RIP3 were constructed and purified by Welgen, Inc (Worcester, MA). In vitro adenovirus infection was performed, as described previously. 30
Flow Cytometric Analysis
Cell death was evaluated using an Annexin V-PE/7-AAD staining kit (BD Biosciences, San Jose, CA) and a Becton Dickinson Biosciences FACSCalibur (BD Biosciences).
In Vivo Propidium Iodide Staining
In vivo cell necrosis was examined by intraperitoneal injection of propidium iodide (PI). 22 Two hours after PI administration, mice were euthanized and perfusion fixed with 4% formaldehyde; 6-μm-thick cryosections were cut. Staining was immediately visualized with a Nikon Eclipse Ti-inverted microscope system, and digital images were acquired using a Nikon DS-Ri1 digital camera.
Statistical Analysis
Data are presented as mean±SEM. Two-tailed Student t test for normally distributed data and Mann-Whitney nonparametric test for skewed data that deviate from normality were used to compare 2 conditions. One-way analysis of variance with Bonferroni post hoc test for normally distributed data and Kruskal-Wallis nonparametric test for skewed data were used to compare ≥3 means. Differences with P<0.05 were considered statistically significant.
Results

Increased Expression of RIP3 and Elevated Necrosis in AAA
To examine RIP3 expression in aneurysm disease, we stained AAA tissues derived from aneurysm patients who 31 in the SMC layer of human AAA tissues ( Figure 1A ; Online Figure I ). The diminished staining of smooth muscle-specific α-actin in AAA tissues reflected the loss of muscle cells, as well as a reduction in contractile proteins in those tissues. We next induced aneurysm in C57BL/6 mice by transient perfusion of infrarenal aortae with porcine pancreatic elastase, an established AAA model. 28, 32 Mice that were perfused with heat-inactivated elastase were used as controls. The affected aortic tissues were harvested for RNA or protein extraction 14 days after aneurysm induction and analyzed by real-time polymerase chain reaction or Western blotting. As shown in Figure 1B , the aneurysm induction by elastase increased levels of Rip3 mRNA and protein in the injured aortic wall by 3.93±0.763-fold (P=0.0003; n=8) and 2.07-fold (P=0.0143; n=4) over the controls, respectively. In contrast, increases in Rip1 mRNA and protein were marginal and did not reach statistical significance (Online Figure IIA and IIB). To further characterize the RIP1-and RIP3-positive cells, we costained aortic tissues with terminal deoxynucleotidyl transferase-mediated dUTP-TMR nick end labeling (TUNEL). No colocalization was noted between RIP3 and TUNEL staining ( Figure 1C ), whereas some high RIP1-expressing cells were also positive for TUNEL (Online Figure IIC) . Because of the lack of specific markers for necroptotic cells, we used propidium iodide (PI) (administered to mice via intraperitoneal injection 2 hours before euthanization) to identify necrotic cells with disrupted cell membrane. 22 As shown in Figure 1D and Online Figure III , compared with control aortae, necrosis increased in the SMC-rich medial layer of elastase-treated aortae. Importantly, those PI-positive cells were positive for smooth muscle-specific α-actin but not CD31, an endothelial cell marker, suggesting that necrosis occurs primarily in SMCs in the elastase-induced AAA model. . Propidium iodide (PI) was administered to mice via intraperitoneal injection 2 hours before euthanization. The necrotic cells (PI-positive) were indicated by white arrows. After PI staining, aortic sections were also stained for CD31 or SM-αA. n=3. Scale bars=100 μm.
Rip3 Deficiency Attenuates AAA Formation
It has been demonstrated in several disease models, including atherosclerosis and photoreceptor death, that Rip3 deficiency inhibits necroptosis but not apoptosis. 16, 22 Therefore, we used Rip3 mutants to probe the potential role of necroptosis in aneurysm pathophysiology. Male Rip3 +/+ , Rip3 +/− , and Rip3 −/− mice, 8-to 12-week-old, were subjected to aneurysm induction by elastase. Western blotting of aortic tissue extracts confirmed the absence of RIP3 protein in Rip3 −/− mice and a markedly reduced RIP3 expression in Rip3 +/− mice (Online Figure IV) . Levels of RIP1 appeared to be comparable in all 3 genotypes. Fourteen days after elastase perfusion, mice were euthanized for the evaluation of aneurysm, defined in this model as ≥100% increase in the maximal external diameter compared with that measured before perfusion. 28 Rip3 gene deletion profoundly inhibited aneurysm formation: 0 of the 9 Rip3 −/− mice and 2 of the 9 Rip3 +/− mice (22.22%) developed aneurysms compared with 8 of the 9 (88.89%) aneurysm incidence in the Rip3 +/+ mice. The mean aortic expansion caused by elastase perfusion was 45.088±5.247% (0.77±0.03 mm) and 62.140±10.175% (0.85±0.04 mm) in Rip3 −/− and Rip3 +/− mice, respectively, which was significantly smaller than the 157.366±9.973% (1.42±0.06 mm) expansion observed in elastase-treated WT mice. The aortic expansions in Rip3 +/− mice appeared to be slightly larger than those seen in Rip3 −/− mice; however, the difference in aortic diameters between the 2 mutant genotypes did not reach statistical significance (P=0.16; Figure 2A ; Online Figure V) . Histologically, the Rip3 gene deficiency protected aortic tissue integrity. Representative images in Figure 2B demonstrate elastin fragmentation and SMC paucity in Rip3 +/+ aortae on day 14 after elastase perfusion. These aneurysm-associated characteristics were profoundly diminished in elastase-perfused Rip3 −/− aortae. Consistent with the known function of RIP3 in necroptosis, in vivo PI staining showed a significant decrease in the number of necrotic cells detected in Rip3 −/− mice on day 7 after elastase perfusion ( Figure 2C ). Because necrotic cells are highly immunogenic, we tested whether Rip3 gene deficiency attenuated vascular inflammation by assessing mRNA levels of cytokines in the elastase-perfused infrarenal region of aorta where aneurysmal expansion occurs. As shown in Figure 2D , the loss of Rip3 profoundly reduced mRNA levels of examined proinflammatory cytokines, including C-C motif ligand2 (CCL2) (monocyte chemoattractant protein-1), tumor necrosis factor-α (TNFα), CCL5, and interferon-γ. Immunofluorescent staining correspondingly revealed reduced macrophage infiltration in arteries harvested from Rip3 −/− mice compared with that in Rip3 +/+ mice ( Figure 2E ).
Rip3 Deficiency in Arterial Wall Is Sufficient to Inhibit Aneurysm Formation
The formation and growth of aortic aneurysm involve a complex interplay between resident cells of the aortic wall and infiltrating inflammatory cells. To delineate the significance of RIP3 in resident aortic cells versus circulating inflammatory cells, we used an aorta transplant model, which we have recently developed ( Figure 3A ). 29 We subjected a Rip3 +/− mouse to aneurysm induction via elastase perfusion, as described for the conventional elastase model, for 5 minutes.
The aortic segment was excised immediately after perfusion and transplanted to the abdominal aorta of a WT-recipient mouse (Rip3 +/− to Rip3 +/+ ). A Rip3 +/+ to Rip3 +/+ transplantation was also performed as a control. Consistent with what we have reported using C57BL/6 mice, 29 the elastase-perfused Rip3 +/+ donor aortae in the Rip3 +/+ recipients became dilated (147.2±14.59%; 1.39±0.09 mm; Figure 3B and 3C; Online Figure VI ) and displayed typical aneurysm characteristics, including elastin fragmentation and SMC depletion ( Figure 3D ). In contrast, none of the 5 elastase-perfused Rip3 +/− donor aortae developed aneurysmal dilatation in Rip3 +/+ recipients (61.01±5.05%; 0.87±0.02 mm; Figure 3B and 3C; Online Figure II ). In addition, elastin fragmentation and SMC depletion in the Rip3 +/− donor aortae were absent ( Figure 3D ). These results suggest that reducing the Rip3 gene by one copy in the aortic wall is sufficient to attenuate aneurysm development, which makes RIP3 an attractive therapeutic target.
RIP3-Dependent SMC Necroptosis
Results from the aorta transplant study indicate that RIP3 upregulation in resident cells of the aortic wall, rather than circulating inflammatory cells, is crucial for aneurysm formation and progression. Because SMCs are most abundant in the aortic wall, we further hypothesized that RIP3 is responsible for death and inflammation of vascular SMCs during aneurysm.
To test this hypothesis, we challenged isolated aortic SMCs with a combination of TNFα (50 ng/mL) and pan caspase inhibitor carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]fluoromethylketone (zVAD; 40 μmol/L), an established in vitro necroptosis induction protocol. 15, 31, 33 As expected, aortic SMCs isolated from C57BL/6 mice ( Figure 4A ) responded to TNFα/zVAD with necrosis. Inhibition of RIP3 by either siR-NA-mediated gene silencing (Rip3 +/+ SMCs) or gene deletion (Rip3 −/− SMCs; Figure 4A and 4B; Online Figure VIIA ) significantly diminished the ability of SMCs to undergo necrosis in response to TNFα/zVAD, which established that the form of necrosis detected here was RIP3-dependent necroptosis. By infecting Rip3 −/− aortic SMCs with increasing concentrations of a RIP3 expressing-adenoviral vector (AdRIP3), we dosedependently restored RIP3 protein expression ( Figure 4B ). Interestingly, Rip3 −/− SMCs that were infected with 1×10 4 multiplicity of infection of AdRIP3 displayed spontaneous necroptosis (21.080±0.922%), which was further enhanced by the TNFα/zVAD treatment ( Figure 4B ). AdRIP3 at 5×10 4 multiplicity of infection caused even higher level of spontaneous necroptosis (24.920±1.414%) and rendered cells insensitive to the TNFα/zVAD treatment ( Figure 4B ). Together, these data demonstrate that the level of RIP3 is a primary determinant of SMC necroptosis.
RIP3 Mediates the Inflammatory Response of SMCs
Vascular SMCs in injured or diseased vessels are a major source of proinflammatory chemokines. 30, 34, 35 We next examined whether RIP3 plays a role in the inflammatory response of SMCs. TNFα is elevated in human AAA 36 and contributes to both CaCl 2 (calcium chloride)-induced and elastase-induced AAAs. 37, 38 Here, TNFα was used as a trigger for inflammation. Aortic SMCs isolated from C57BL/6 mice were treated with 10 ng/mL TNFα for 2 hours. At this condition, TNFα itself Figure 5A ). We then examined the inflammatory gene and adhesion molecule expression by real-time polymerase chain reaction. As shown in Figure 5B , compared with control siRNA, RIP3 siRNA significantly reduced Ccl2 expression by 66.2%, Il6 expression by 29.8%, Tnf expression by 58.2%, and Vcam1 expression by 27.9%. In contrast, Ccl5, Ccl7, Il1b, Icam1, and Mmp2 mRNA levels were not significantly affected by Rip3 knockdown (Figure 5B ). Because TNFα is known to stimulate gene expression of chemokines through the NFκB pathway, we compared NFκB signaling in Rip3 +/+ and Rip3 −/− SMCs. Although both genotypes responded to TNFα with comparable IκB degradation, phosphorylation of p65 on serine536 was profoundly diminished by Rip3 gene knockout ( Figure 5C ). In contrast, RIP3 deletion did not alter the phosphorylation status of p65 at Ser276 (Online Figure VIII) or nuclear retention of p65 after TNFα treatment (Online Figure IX) . Furthermore, using an antibody that recognizes an epitope that overlaps with the nuclear localization signal of the p65 subunit, we examined level of the activated form of NFκB. As shown in Figure 5D and Online Figure X , aneurysm induction caused a robust increase in activation of p65 in aortic SMCs of Rip3 +/+ mice. NFκB activation was significantly reduced in Rip3-deficient mice.
PKCδ Is Required for SMC Necroptosis
PKCδ is endogenously expressed by vascular SMCs 39 and becomes upregulated in injured arteries and aneurysmal tissues. 10, 40 We have previously demonstrated that PKCδ plays an important role in SMC apoptosis 41 and chemokine expression. 30 Prkcd −/− mice are resistant to aneurysm inductions in both calcium chloride-induced and elastase-induced mouse models of AAA. 10 Interestingly, coimmunostaining revealed that the RIP3 and PKCδ are coexpressed in the SMC-rich medial layer of mouse aneurysmal tissues ( Figure 6A ). To delineate functional interactions between RIP3 and PKCδ, we subjected aortic SMCs isolated from Prkcd −/− mice and their WT littermates to necroptosis Figure 5 . Receptor-interacting protein 3 (RIP3) is involved in tumor necrosis factor-α (TNFα)-induced cytokine expression in aortic smooth muscle cells (SMCs). A, Aortic SMCs isolated from C57BL/6 mice were treated with TNFα (10 ng/mL) or phosphate buffered saline (PBS) for 2 hours. The absence of cell death induced by TNFα at this concentration was confirmed by flow cytometry. n=2. B, Aortic SMCs were transfected with control or RIP3-specific siRNA. After 48 hours, cells were stimulated with 10 ng/mL TNFα for 2 hours for cytokines and Mmp2 or 2 ng/mL TNFα for 4 hours for Vcam1 and Icam1. mRNA levels were determined by real-time polymerase chain reaction. Data are mean±SEM. n=4. C, Aortic SMCs isolated form Rip3 +/+ and Rip3 −/− mice were treated with 10 ng/mL TNFα for indicated time. Cell lysates were subjected to Western blot analysis with indicated antibodies. *P<0.05. Data represent mean±SEM. n=4. D, Representative photographs of aortic cross sections harvested from mice on day 7 postperfusion with elastase. Sections were costained for active p65 and smooth muscle α-actin (SM-αA). n=3. Scale bars=50 μm. 7-AAD indicates 7-aminoactinomycin D; and L, lumen.
induction with TNFα/zVAD. Prkcd +/+ SMCs responded to the TNFα/zVAD treatment with necrosis that was inhibited by necrostatin-1. However, Prkcd −/− SMCs failed to undergo necrostatin-1-sensitive necroptosis ( Figure 6B ). Similar necroptosis resistances in both primary cultured aortic SMCs from C57BL/6 mice and MOVAS cells (a mouse aortic SMC line) were also produced by siRNA-mediated transient knockdown of Prkcd ( Figure 6C; Online Figures VIIB and XIA) . Restoration of PKCδ expression with a PKCδ-expressing adenovirus rescued sensitivity to necroptosis induction ( Figure 6D) . Notably, knocking down Prkcd in L929, a murine aneuploid fibrosarcoma cell line widely used in necroptosis studies, 42 did not protect cells from necroptosis (Online Figure XIB) , indicating that the involvement of PKCδ in necroptosis might be cell-type specific.
PKCδ Regulates RIP3 Expression in SMCs
Given the importance of cellular RIP3 level in necroptosis, we next analyzed RIP3 expression in aortic SMCs isolated from Prkcd −/− mice and their WT littermates. As shown in Figure 7A , levels of RIP3 mRNA and protein were markedly reduced in Prkcd −/− SMCs compared with those in WT SMCs. RIP1 protein level was not significantly changed by PKCδ deficiency. Transient knockdown of Prkcd in SMCs isolated from C57BL/6 mice also produced a significant downregulation of RIP3 ( Figure 7B ). Adenoviral vectors expressing PKCδ-mediated restoration of PKCδ expression in Prkcd −/− SMCs dose-dependently corrected RIP3 protein contents ( Figure 7C) . Moreover, analysis of Rip3 expression in tissue extracts from our prior PKCδ study showed a significantly lower level of aneurysm-associated RIP3 expression in the aortic wall of Prkcd −/− mice compared with that in the WT mice (Online Figure XII) . Collectively, these data demonstrate an essential role of PKCδ in controlling RIP3 expression in aortic SMCs under both resting and stressed conditions.
To further delineate the functional relationship between PKCδ and RIP3 in necroptosis, we ectopically expressed RIP3 in Prkcd −/− SMCs using AdRIP3 ( Figure 7D ). AdRIP3 successfully rescued the necroptosis response in the absence of PKCδ 
Discussion
The aneurysm-resistant phenotype rendered by Rip3 heterozygous and homozygous gene deletion, along with elevated RIP3 expression detected in human and experimental aneurysmal tissues, highlights the importance of RIP3 in aneurysm pathophysiology. The finding that aortic segments from Rip3 +/− mice were resistant to elastase-induced AAA even when allografted to the aortae of Rip3 +/+ mice indicates that RIP3 in cells resident to the aortic wall, most likely SMCs, is critical for the development of aneurysm.
Because of the lack of a specific histological marker of necroptosis, we were unable to determine in vivo to what degree the lack of RIP3 inhibits necroptosis. Despite this, we found that the number of PI-positive necrotic cells, which include necroptotic cells, was markedly reduced in Rip3 −/− aortae compared with that in Rip3 +/+ aortae after elastase perfusion. Necrosis is considered a proinflammatory event, and thus suppression of vascular inflammation by Rip3 deficiency is not unexpected. However, our data suggest that in aortic SMCs, RIP3 may directly modulate inflammation. The necroptosis-independent function of RIP3 in inflammation is supported by the following: (1) in isolated aortic SMCs, knockdown or knockout Rip3 attenuated TNFα-induced phosphorylation of p65 ser-ine536 and expression of several proinflammatory cytokines;
(2) after elastase perfusion, we observed reduced p65 activation in Rip3-deficient aortae compared with that in Rip3 +/+ aortae.
We therefore propose a model that elevated RIP3 in the aortic wall contributes to aneurysm pathogenesis through both necroptosis-dependent and necroptosis-independent mechanisms (Figure 8 ). In this model, RIP3 mediates SMC necroptosis by initiating necrosome formation and also actively involves in inflammation by stimulating NFκB. It is unclear whether cross-talks occur between these 2 RIP3-mediated RIP3 is upregulated in the injured aneurysmal wall via a protein kinase C-delta (PKCδ)-mediated mechanism (transcription factor X [TF X]). In the presence of elevated RIP3, smooth muscle cells (SMCs) respond to tumor necrosis factor-α or other cytokines by undergoing necroptosis or nuclear factor-κB (NFκB)-mediated chemokine/cytokine production. The precise determinants that switch RIP3 between necroptosis and NFκB in SMCs remain unclear; however, both processes may contribute to inflammation in aortic wall during abdominal aortic aneurysm development and progression.
pathways. Clarke et al 43 show that primary necrotic SMCs release IL1α, which could subsequently cause the neighboring viable aortic SMCs to produce IL6 and monocyte chemoattractant protein-1. Because necroptosis is a form of primary necrosis, a similar mechanism is likely to exist downstream from necrosome formation, as indicated in Figure 8 by a dotted arrow.
Our data of the direct involvement of RIP3 in NFκBmediated vascular inflammation add support to the notion of necroptosis-independent function of RIP3, which has only been reported in a few studies thus far. 44, 45 Interestingly, we found in aortic SMCs that Rip3 knockdown significantly attenuated TNFα-induced expression of Ccl2 (monocyte chemoattractant protein-1), Il6, Tnf, and Vcam1 but not Ccl5, Ccl7, Il1b, Icam1, or Mmp2. Because all these molecules are known to be regulated by NFκB, we speculate that the selective requirement of RIP3 might be related to their sensitivity to serine536 phosphorylation of p65, which was attenuated in Rip3 −/− SMCs treated with TNFα. Among the multiple phosphorylation sites within p65, serine536 is critical for enhancing the transcriptional activity of NFκB by recruitment of TATA-binding protein-associated factor II31. 46 It is possible that not all cytokine genes require this fine-tuning mechanism for optimal expression.
Apoptosis and necrosis are 2 major mechanisms through which cell death occurs. Recent findings suggest that apoptosis and necroptosis are not mutually exclusive mechanisms, perhaps taking place in the same disease process. 14, 22 Multiple factors identified in aneurysmal tissues, such as TNFα 13, 37, 38 and Fas ligand, 13, 47 could trigger apoptosis, as well as necroptosis. The molecular network regulating necroptosis is known to intertwine with apoptotic regulators, 13, 14 one such example being the involvement of RIP1 in both apoptosis and necroptosis. 47, 48 Indeed, we found that many RIP1-positive cells were also apoptotic, evidenced by double-positive for TUNEL. In comparison, none of elastase-treated aortic sections we examined contained RIP3 and TUNEL double-positive cells. The lack of direct involvement of RIP3 in the apoptotic pathway is supported by the published observations that Rip3 deficiency inhibits necroptosis but not apoptosis. 16, 22 Atherosclerosis and AAA share many common risk factors, including aging and smoking. Mechanistically, chronic inflammation underlies both types of vascular disease. Data generated by this study and by the previous work implicate that RIP3 contributes to disease progression of both AAA and atherosclerosis, 16 although, through discrete mechanisms. We show here that loss of Rip3 in the aortic wall was sufficient to protect mice from AAA, whereas Lin et al 16 found that Rip3 deficiency in vascular wall is not responsible for the diminished atherosclerotic lesion burden. Although our arterial transplant experiments support the importance of RIP3 in the vascular wall, we cannot exclude a potential role for RIP3 in circulating inflammatory cells. Generation of cellspecific knockouts will be beneficial to our understanding of cell-specific functions of RIP3 in aneurysm, as well as other diseases. Another interesting divergent result from these 2 disease models is the phenotype of Rip3 heterozygous mutants. Rip3 +/− ;Apoe −/− mice develop atherosclerotic plaques that are smaller than those in Rip3 +/+ ;Apoe −/− mice but larger compared with Rip3 −/− ;Apoe −/− mice. 16 Our data demonstrated that Rip3 +/− mice developed significantly smaller aortic dilatations in response to the AAA induction compared with their WT littermates. However, statistical analysis showed no difference in aortic dilatations between Rip3 +/− and Rip3 −/− mice.
Prkcd gene-deficient mice are highly resistant to aneurysm development triggered by 2 different experimental methods, and vascular SMC death is attenuated in Prkcd −/− mice. 10 At the time, we attributed this observation to the stimulatory role of PKCδ in apoptosis and chemokine expression. The current findings indicate a new role of PKCδ in regulating necroptosis in vascular SMCs, which is at least in part through the regulation of Rip3 gene expression. RIP3 expression is essential for cells to undergo necroptosis. 15, 31, 48 In support of this notion, we showed that overexpression of RIP3 in Rip3 −/− SMCs via an adenoviral vector was sufficient to elicit necroptosis in the absence of exogenous triggers. Of note, adenovirus-mediated expression of RIP3 in Prkcd −/− SMCs failed to induce necroptosis in the absence of TNFα and zVAD as it did in Rip3 −/− SMCs. The exact causes of this discrepancy are unclear; however, several factors might be involved. First, Prkcd −/− mice are on a mixed background of C57BL/6 and 129/Sv, whereas Rip3 −/− mice are on a C57BL/6J background. These different genetic backgrounds can well affect the necroptosis response. Second, PKCδ is a critical mediator of SMC apoptosis. 30, 41 Overexpression of PKCδ may activate several downstream signaling pathways in addition to RIP3. Finally, it is also possible that PKCδ may be required for optimal activation of RIP3.
Although PKC is reported to be required for a pan caspase inhibitor zVAD-fmk (zVAD)-induced necroptosis in L929 cells by regulating autocrine TNFα production via the PKC-MAPKs-AP-1 pathway, 49 knocking down PKCδ in L929 appeared to have little effects on necroptosis, suggesting that the involvement of PKCδ in necroptosis is likely to be cell-type specific.
Several mouse models have been created for AAA, each with unique strengths and weaknesses. 32 The elastase-induced mouse model of AAAs used here is a widely used model that recapitulates the major pathological features of human AAA, including SMC depletion, inflammation, and elastin degradation. 28, 32 There are several limitations associated with this model. For example, AAA rupture, a major complication in human AAA, 7 is rare in this model. Mechanical effects of elastase perfusion and variability from different commercial elastase preparation are also noted in this model. 32 It is important to recognize that none of current animal models reproduces all aspects of human AAAs. In our study, we did not detect significant changes in RIP1 in the elastase-induced aneurysms, whereas this protein, which is known for its role in apoptosis, necroptosis and cell survival, was found to be elevated in human aneurysmal tissues. Whether this discrepancy reflects different regulation of RIP1 in human versus mouse or a limitation of the particular aneurysm model used in our studies remains to be tested.
To summarize, through the use of Rip3 gene-deficient mice and an aorta transplant model, we demonstrate for the first February 13, 2015 time that enhanced RIP3 signaling in arterial wall is a critical pathological process during aneurysm progression, at least in elastase-induced mouse model of AAA. Mechanistic studies demonstrate a critical role for RIP3 in mediating SMC necroptosis, as well as NFκB-mediated inflammatory response in SMCs. Notably, overexpression of RIP3 is sufficient to induce necroptosis in SMCs, suggesting the importance of RIP3 expression level in determining cell necroptosis. Interestingly, PKCδ is necessary for RIP3 expression and necroptosis in SMCs, although this role for PKCδ may be cell-type specific.
